E-ISSN: 1308-5263
Hematological Malignancy Patients, COVID-19, and Favipiravir [Turk J Hematol]
Turk J Hematol. 2021; 38(4): 331-332 | DOI: 10.4274/tjh.galenos.2021.2021.0582  

Hematological Malignancy Patients, COVID-19, and Favipiravir

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2
1Private Academic Consultant, Bangkok, Thailand
2D.Y. Patil University, Pune, India

Keywords: Malignancy, COVID-19, Favipiravir


Hematolojik Malignite Hastalarư, COVID-19 ve Favipiravir

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2
1Private Academic Consultant, Bangkok, Thailand
2D.Y. Patil University, Pune, India

Anahtar Kelimeler: COVID-19, Favipiravir


Rujittika Mungmunpuntipantip, Viroj Wiwanitkit. Hematological Malignancy Patients, COVID-19, and Favipiravir. Turk J Hematol. 2021; 38(4): 331-332

Corresponding Author: Rujittika Mungmunpuntipantip, Thailand


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2020) = 1.831